Adma Biologics, Inc. (ADMA)

Trade ADMA now with
7/8/2019 8:33:54 AM ADMA Biologics Receives FDA Approval For License Transfers For BIVIGAM And Nabi-HB
5/10/2019 7:10:57 AM ADMA Biologics: FDA Approves Prior Approval Supplement For BIVIGAM; Says It Will Commence Commercial Sales Of BIVIGAM
4/4/2019 8:04:37 AM WBB Securities Raises ADMA BIOLOGICS, INC. (ADMA) To Buy From Speculative Buy With $11.50 Price Target
1/7/2019 7:20:55 AM ADMA Biologics Submits Response And Provides Supplemental Information To FDA For BIVIGAM CRL
12/17/2018 7:02:43 AM WBB Securities Starts ADMA BIOLOGICS, INC. (ADMA) At Speculative Buy With $9 Price Target
10/17/2018 7:09:20 AM ADMA Biologics Receives PDUFA Date Of April 2, 2019 For RI-002
10/11/2018 8:49:31 AM ADMA Biologics Provides Regulatory Update For BIVIGAM
10/3/2018 7:12:29 AM ADMA BioCenters Gets FDA Approval For Third Plasma Collection Center
10/1/2018 7:09:15 AM ADMA Biologics Resubmits BLA For RI-002
9/5/2018 8:11:30 AM LabConnect Appoints Eric Richman As Chairman
9/5/2018 7:09:03 AM ADMA Biologics Reports FDA Inspection Database Confirms VAI Status Of Boca Raton, FL Facility
8/10/2018 7:10:01 AM ADMA Biologics Q2 Net Loss $14.7 Mln Or $0.35/Shr Vs Loss Of $9.0 Mln Or $0.55/Shr Last Year